Background: Diabetic patients receiving high-intensity statins represent a high-risk subgroup for cardiovascular (CV) events. The observed CV event risk in this patient group might not align with the predicted risk… Click to show full abstract
Background: Diabetic patients receiving high-intensity statins represent a high-risk subgroup for cardiovascular (CV) events. The observed CV event risk in this patient group might not align with the predicted risk from published risk equations. Methods: We compared observed to predicted CV event
               
Click one of the above tabs to view related content.